Q3 2024 |
55 |
$3.42B |
+$89.1M |
-$559M |
-$470M |
MLTX, KYMR, RVMD, MIRM, TYRA
|
13F-HR |
11/14/2024, 04:00 PM |
Q2 2024 |
60 |
$3.57B |
+$442M |
-$216M |
+$226M |
MLTX, RVMD, KYMR, IONS, MIRM
|
13F-HR |
8/14/2024, 04:10 PM |
Q1 2024 |
62 |
$3.64B |
+$143M |
-$747M |
-$603M |
MLTX, KYMR, RVMD, FDMT, GHRS
|
13F-HR |
5/15/2024, 04:01 PM |
Q4 2023 |
70 |
$4B |
+$312M |
-$468M |
-$156M |
MLTX, RVMD, AXSM, PTGX, KYMR
|
13F-HR |
2/14/2024, 04:02 PM |
Q3 2023 |
69 |
$3.71B |
+$352M |
-$108M |
+$244M |
MLTX, IONS, AXSM, IDYA, MIRM
|
13F-HR |
11/14/2023, 04:00 PM |
Q2 2023 |
67 |
$3.59B |
+$214M |
-$237M |
-$23.6M |
MLTX, RVMD, AXSM, IDYA, IONS
|
13F-HR |
8/14/2023, 04:01 PM |
Q1 2023 |
72 |
$2.74B |
+$494M |
-$197M |
+$297M |
MLTX, KYMR, AXSM, RVMD, IONS
|
13F-HR |
5/15/2023, 04:00 PM |
Q4 2022 |
78 |
$2.37B |
+$332M |
-$391M |
-$59.2M |
MLTX, AXSM, RPTX, KYMR, GHRS
|
13F-HR |
2/14/2023, 04:00 PM |
Q3 2022 |
80 |
$2.42B |
+$303M |
-$153M |
+$150M |
MLTX, IONS, GHRS, KYMR, RPTX
|
13F-HR |
11/14/2022, 04:05 PM |
Q2 2022 |
79 |
$2.07B |
+$386M |
-$256M |
+$130M |
RPTX, MLTX, RCUS, CGEM, GHRS
|
13F-HR |
8/15/2022, 04:45 PM |
Q1 2022 |
81 |
$2.5B |
+$458M |
-$176M |
+$282M |
GHRS, KYMR, RLAY, RCUS, MRUS
|
13F-HR |
5/16/2022, 04:15 PM |
Q4 2021 |
83 |
$2.76B |
+$636M |
-$238M |
+$398M |
GHRS, KYMR, RCUS, MRUS, PTGX
|
13F-HR |
2/14/2022, 04:01 PM |
Q3 2021 |
75 |
$2.56B |
+$505M |
-$387M |
+$118M |
GHRS, KYMR, OLMA, RCUS, ARGX
|
13F-HR |
11/15/2021, 04:03 PM |
Q2 2021 |
70 |
$2.67B |
+$604M |
-$519M |
+$85.3M |
GHRS, ARGX, OLMA, PTGX, MRUS
|
13F-HR |
8/16/2021, 04:23 PM |
Q1 2021 |
67 |
$2.67B |
+$611M |
-$527M |
+$84.1M |
FPRX, OLMA, MRUS, XOMA, RVMD
|
13F-HR |
5/17/2021, 04:03 PM |
Q4 2020 |
68 |
$2.54B |
+$704M |
-$660M |
+$44.5M |
OLMA, XOMA, KYMR, RLAY, RVMD
|
13F-HR |
2/12/2021, 04:03 PM |
Q3 2020 |
62 |
$1.84B |
+$528M |
-$303M |
+$225M |
RLAY, SWTX, RPTX, KYMR, XNCR
|
13F-HR |
11/13/2020, 09:45 AM |
Q2 2020 |
57 |
$1.62B |
+$478M |
-$235M |
+$243M |
SWTX, PRNB, ARGX, IONS, MRUS
|
13F-HR |
8/14/2020, 03:06 PM |
Q1 2020 |
57 |
$1.07B |
+$179M |
-$222M |
-$42.9M |
PRNB, IONS, ACIU, SWTX, XOMA
|
13F-HR |
5/15/2020, 03:30 PM |
Q4 2019 |
57 |
$1.32B |
+$373M |
-$250M |
+$122M |
IONS, SWTX, ACIU, PRNB, CYTK
|
13F-HR |
2/14/2020, 04:43 PM |
Q3 2019 |
59 |
$952M |
+$270M |
-$140M |
+$129M |
MRUS, SWTX, IONS, ACIU, CYTK
|
13F-HR |
11/14/2019, 03:47 PM |
Q2 2019 |
56 |
$916M |
+$159M |
-$233M |
-$73.6M |
MRUS, CYTK, ARRY, ACIU, MRTX
|
13F-HR |
8/14/2019, 03:00 PM |
Q1 2019 |
53 |
$893M |
+$99.8M |
-$199M |
-$99.6M |
ARRY, MRUS, BPMC, KURA, FPRX
|
13F-HR |
5/15/2019, 04:00 PM |
Q4 2018 |
55 |
$765M |
+$82.1M |
-$117M |
-$35.2M |
CCXI, ARRY, MRUS, KURA, BPMC
|
13F-HR |
2/14/2019, 01:31 PM |
Q3 2018 |
57 |
$1.14B |
+$192M |
-$61.2M |
+$131M |
ARRY, CCXI, MRUS, CYTK, FPRX
|
13F-HR |
11/14/2018, 04:21 PM |
Q2 2018 |
51 |
$1.02B |
+$218M |
-$195M |
+$23.6M |
CCXI, MRUS, ARRY, CYTK, ARQL
|
13F-HR |
8/14/2018, 01:41 PM |
Q1 2018 |
43 |
$986M |
+$237M |
-$188M |
+$49.5M |
CCXI, IRWD, ARRY, BPMC, ARQL
|
13F-HR |
5/7/2018, 05:16 PM |
Q4 2017 |
43 |
$830M |
+$210M |
-$324M |
-$114M |
ARRY, ANAB, BPMC, XOMA, CNCE
|
13F-HR |
2/14/2018, 03:08 PM |
Q3 2017 |
37 |
$787M |
+$197M |
-$144M |
+$52.7M |
ARRY, BPMC, CCXI, ANAB, CNCE
|
13F-HR |
11/14/2017, 02:40 PM |
Q2 2017 |
34 |
$644M |
+$125M |
-$80.8M |
+$44.6M |
BPMC, CCXI, ARRY, ANAB, LOXO
|
13F-HR |
8/14/2017, 02:50 PM |
Q1 2017 |
30 |
$588M |
+$138M |
-$141M |
-$2.98M |
BPMC, CCXI, CYTK, ANAB, CNCE
|
13F-HR |
5/15/2017, 03:26 PM |
Q4 2016 |
29 |
$498M |
+$70.1M |
-$94.8M |
-$24.7M |
BPMC, CYTK, CCXI, ARRY, CNCE
|
13F-HR |
2/14/2017, 03:13 PM |
Q3 2016 |
29 |
$531M |
+$72.2M |
-$140M |
-$68.1M |
BPMC, CCXI, CYTK, ARRY, CASC
|
13F-HR |
11/14/2016, 05:24 PM |
Q2 2016 |
34 |
$469M |
+$98.9M |
-$78.6M |
+$20.3M |
BPMC, CYTK, CCXI, CNCE, ARRY
|
13F-HR |
8/15/2016, 04:39 PM |
Q1 2016 |
32 |
$404M |
+$67.8M |
-$42.8M |
+$25M |
BPMC, CNCE, CYTK, FWP, ONTY
|
13F-HR |
5/16/2016, 04:02 PM |
Q4 2015 |
30 |
$587M |
+$124M |
-$93.6M |
+$30.5M |
BPMC, CCXI, CTIC, CNCE, ONTY
|
13F-HR |
2/16/2016, 03:36 PM |
Q3 2015 |
27 |
$495M |
+$92.3M |
-$73M |
+$19.3M |
IRWD, CCXI, ONTY, ARRY, CNCE
|
13F-HR |
11/16/2015, 04:54 PM |
Q2 2015 |
30 |
$567M |
+$119M |
-$86.5M |
+$32.3M |
ARRY, CCXI, BPMC, FWP, CNCE
|
13F-HR |
8/14/2015, 05:00 PM |
Q1 2015 |
30 |
$478M |
+$28.3M |
-$141M |
-$113M |
ARRY, CCXI, IRWD, FWP, OMED
|
13F-HR |
5/15/2015, 04:22 PM |
Q4 2014 |
31 |
$514M |
+$92.2M |
-$153M |
-$60.6M |
IRWD, CCXI, ARRY, LGND, OMED
|
13F-HR |
2/17/2015, 04:27 PM |
Q3 2014 |
32 |
$482M |
+$81.7M |
-$104M |
-$22.2M |
IRWD, RCPT, LGND, ARRY, CCXI
|
13F-HR |
11/14/2014, 04:15 PM |
Q2 2014 |
29 |
$632M |
+$87M |
-$34.9M |
+$52.1M |
IRWD, LGND, ARRY, CCXI, RCPT
|
13F-HR |
8/14/2014, 04:15 PM |
Q1 2014 |
27 |
$600M |
+$39.1M |
-$104M |
-$64.6M |
LGND, IRWD, CCXI, ARRY, OMED
|
13F-HR |
5/15/2014, 05:05 PM |
Q4 2013 |
26 |
$572M |
$0 |
$0 |
|
LGND, IRWD, CCXI, ARRY, OMED
|
13F-HR |
2/14/2014, 04:39 PM |